Solvency from a dilutionary cap. raising I bet. I don't think holders have a clear view of the blue sky just yet.
Gotta ask why the old managment took the convertible notes and not the equity.
Morphosys was the company Novartis transacted with.
Solvency from a dilutionary cap. raising I bet. I don't think...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.035(2.46%) |
Mkt cap ! $810.7M | |||
| Open | High | Low | Value | Volume |
| $1.42 | $1.42 | $1.37 | $20.33K | 14.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 721 | $1.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 839 | 1 |
View Market Depth
| Last trade - 10.58am 23/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |